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Objectives: What constitutes an adequate margin of resection for infiltrative subtypes of soft-tissue
sarcomas remains unclear. We aimed to determine the prognostic significance of the margin in milli-
metres for myxofibrosarcoma (MFS) and undifferentiated pleomorphic sarcoma (UPS).
Methods: 305 patients diagnosed with either a high-grade, localised MFS (n¼ 98) or UPS (n¼ 207) were
included. The relationship of closest margin in millimetres to viable tumour and oncological outcomes
was analysed.
Results: The overall local recurrence (LR) rate for all patients were 12%: 19% with positive margin and 10%
with negative margin (p ¼ 0.051). The LR rate was similar in patients with negative but <10 mm margin;
13%, 6%, 15%, 17% with 0.1e0.9 mm, 1.0e1.9 mm, 2.0e4.9 mm, and 5.0e9.9 mm margin, respectively.
However, the LR rate decreased to 3% if the margin was 10 mm. By the R- or Rþ1-classification, the 10-
year cumulative probability of LR was 9%, 15%, 48% for R0, R1, R2 resections, respectively, which was not
sensitive enough to stratify the LR risk in patients with negative margins. However, the cumulative
probability of LR was significantly stratified by metric distance; the 10-year cumulative LR probability
was 3%, 14%, 25% with 10.0 mm, 0.1e9.9 mm, and 0 mm, respectively (p¼ 0.026). A trend towards
improved local control by adjuvant radiotherapy was seen in patients with 0e9.9mmmargin (p¼ 0.078).
Conclusion: The resection margin, when measured as a metric distance, correlates with a reduction in LR,
and appears to be more significant on local control than radiotherapy. To minimise the risk of LR, a
margin distance of at least 10mm is advocated for MFS and UPS.
© 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical
Oncology. All rights reserved.Introduction
The significance of a wide resection margin in local control of
soft tissue sarcomas (STSs) has been emphasized for decades [1e8].
While several authors have demonstrated that tumours resected
with positive margins have a significantly higher rate of local
recurrence [2,3,5,6,9e13], there is no consensus on what is an
adequate margin distance for minimizing the risk of local recur-
rence. To date, several investigations have attempted to quantify
the distance associated with a reduced risk of LR. Dickinson et al.
stratified patients into five groups (contaminated, < 1mmbut clear,
1e4mm, 5e9mm, and 10e19mm) and concluded that a margin
greater than 1mm was satisfactory for local control of STSs [5].ospital, Bristol Road South,
ra).
on for Cancer Surgery, and the EurSampo et al. reported that the incidence of LR correlated with
increasing surgical margin, from 0 to 4 cm, and concluded that a
surgical margin of 2e3 cm is ‘reasonable’ [6]. However, these pre-
vious investigations were performed using patient cohorts con-
sisting of a variety of STSs including tumour types with an
infiltrative margin, which are associated with higher rates of local
recurrence [14].
Myxofibrosarcoma (MFS) and undifferentiated pleomorphic
sarcoma (UPS) frequently present with an infiltrative growth
pattern [15e18]. This infiltrative growth pattern was first reported
in 1999 by Fanburg-Smith et al., where pathological infiltrationwas
observed in patients with 83% of superficial and 24% of deep MFH
(now termed UPS) [15]. In a retrospective review of 89 patients
diagnosed with MFS or UPS, Iwata et al. observed infiltrative
growth in 36% of MFS and 22% of UPS on preoperative MRI, which
was defined as a tail-like extensive lesion along the normal fascial
plane [17]. Although their surgical protocol was to excise 2e3 cmopean Society of Surgical Oncology. All rights reserved.
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surgical margin was positive in 48% (n¼ 43/89) and 5-year local
recurrence-free survival was 81%. These outcomes underscore the
difficulty of achieving widemargins for infiltrative subtypes of soft-
tissue sarcomas [19]. Therefore, it would be preferable to analyse
margin adequacy based on the narrower view focusing on the STS
subtypes with infiltrative nature, which has been unclear to date.
In this study, we aimed to determine the significance of margin
adequacy in millimetres on local control for the infiltrative sub-
types of STS, namely MFS and UPS.
Patients and methods
This study was approved by the institutional review board and
all datawas collected from the clinical records and imaging systems
as part of routine patient follow-up.
We conducted a retrospective review of patients diagnosed with
MFS and UPSwho underwent surgical treatment between 1996 and
2016. The histological diagnoses of these subtypes were deter-
mined by experienced pathologists and defined according to the
latest version of World Health Organization (WHO) classification
[20,21]. Only patients with a primary, high-grade sarcoma without
metastatic disease at presentation were included. A minimum of
two years follow-up was required for patients who remained alive.
Those with low-grade and/or metastatic disease at presentation
were excluded. Patients whose pathological details, including
resection margin in millimetres, was unavailable were also
excluded from this study.
All cases were discussed at a multidisciplinary team meeting in
order to develop final management plans. Our policy for defining
the area of resection was to undertake wide excision, including the
tail-sign region identified on the preoperative magnetic resonance
(MR) images, with the surrounding normal tissue. The decision to
use radiotherapy was individualised and varied from patient to
patient; however, radiotherapy was generally advised for patients
with large or high-grade tumours, close or contaminated surgical
margins or tumours located in areas where LR would be difficult to
manage after resection, such as the axilla. Tumour-related factors
including age at diagnosis, sex, histopathological diagnosis, tumour
site, tumour size, tumour depth, histological grade, and tumour
stage were collected from the patient records. Treatment-related
factors obtained included surgical margin, adjuvant therapy
(chemotherapy and radiotherapy), follow-up data including local
recurrence and distant metastasis, follow-up period, and oncolog-
ical outcome. Tumour size was determined as the greatest diameter
of the tumour measured on the resected specimens. Tumour grade
was classified according to the Trojani grading system [22]. Tumour
stage was classified according to the UICC classification [23]. The
closest resection margin was evaluated by pathologists highly
experienced in bone and soft-tissue sarcomas following gross and
microscopic examinations of the specimen. The resection margin in
millimetres was classified according to the conventional R-classi-
fication (R0, macroscopic and macroscopic negative margin; R1,
microscopically positive margin or marginal resection along a
pseudo-capsule; R2, macroscopically positive margin) [24] and
Rþ1-classification (R0, margin with  1 mm; R1, margin with
<1 mm; R2, macroscopic positive margin) [25], and also cat-
egorised according to the results regarding the correlation between
the margin and LR.
The primary end point of the analysis in this studywas LR. Crude
cumulative incidence was estimated for LR using a competing risk
analysis. Death or metachronous distant metastases, whichever
occurred first, was regarded as a competing event to LR. Multivar-
iate analysis was performed using Fine and Gray model and
calculated subdistribution hazard ratios (HRs) for the finalpredictor variables [26e29]. Statistical analyses were performed
using the R version 3.5.5. Differences were considered to be sta-
tistically significant at p< 0.05.
Results
Patient characteristics
A total of 305 patients were available for analysis. The patient
demographics, tumour characteristics and treatments received
summarised in Table 1. The mean age at diagnosis was 67 years
(range, 9e99 years). There was a slight male predominance
(n¼ 160; 52%). 183 tumours (60%) were located in the lower ex-
tremity and 66 tumours (22%) were located in the upper extremity.
Most tumours were grade 3 (82%), with the remaining 18% grade 2.
Approximately half of the patients (54%) had tumours located deep
to the fascia. The histopathological diagnosis was myxofi-
brosarcoma in 98 patients (32%) and undifferentiated pleomorphic
sarcoma in 207 (68%). Themean tumour size defined as the greatest
diameter of the tumour as measured from the excised specimen,
was 9.2 cm (range, 2e31 cm). The stage of disease at presentation
was IIA in 67 patients (22%), IIB in 115 (38%), and III in 123 (40%).
Adjuvant chemotherapy and/or radiotherapy was performed in 13
patients (4%) and 245 (80%), respectively.
Resection margin of millimetres and local control
The relationship of margin in millimetres and LR is summarised
in Table 2. The overall LR rate for all patients was 12% (n¼ 35/304).
The incidence of LR for patients in whom a positive resection
marginwas achieved was 19% (n¼ 11/59), whilst for those inwhom
a negativemarginwas achieved, the rate of LRwas 10% (n¼ 24/245)
(p¼ 0.051). The LR rate was higher in macroscopically positive
patients (R2) (33%; n¼ 7/21) when compared to microscopically
positive patients (11%; n¼ 8/76). In patients with negative margin,
the LR rate was not significantly different among patients with
margin <10mm when compare to those with a margin of
0.1e0.9mm (13%), a margin of 1.0e1.9mm (6%), a margin of
2.0e4.9mm (15%), and amargin of 5.0e9.9mm (17%). However, the
LR rate decreased to less than 5% if the margin was >10mm
(Table 2).
When classified according to the R- and Rþ1-system, the crude
cumulative probability of LR at 10 years was 9%, 15%, and 48% in R0,
R1, and R2 resections, respectively (p < 0.001; Fig. 1A and B). No
significant differences in the cumulative probability of LR were
observed with regards to R0 or R1 resection using either system
(p ¼ 0.643, R-classification; p ¼ 0.535; Rþ1-classification), indi-
cating that this system is not sensitive enough to stratify the LR risk
for patients with clear margin in these infiltrative subtypes of STS.
On the other hand, when margins were categorised into three
groups; positive margin (group 1), negative margin <10mm (group
2), or negative margin >10mm (group 3); based on the outcomes
summarised in Table 2, a significant difference was observed be-
tween groups in terms of the cumulative probability of LR. The 10-
year probability of 25% in group 1, 14% in group 2, and 3% in group 3
(p¼ 0.026; Fig. 1C).
Multivariate analysis was performed separately for R-classifi-
cation, Rþ1-classification, and the three-group classification using
Fine and Gray subdistribution hazard model. In all cases, the
resection margin was identified as a significant factor, whereas
tumour size, depth, grade and adjuvant radiotherapy did not have a
significant influence (Table 3). In terms of R-classification, R2
resection was a significant hazard for LR (R2: HR, 5.923; 95% CI,
2.393e14.660; p < 0.001 versus R0 HR, 1). In Rþ1-mm classifica-
tion, R2 resection was still a significant hazard for LR (R2: HR,
Table 1
Patient characteristics.
Variables Definition No. of
patients
%,
range
Total 305 e
Age at diagnosis (median) 67 9e99
Gender Male 160 52%
Female 145 48%
Site Lower extremity 183 60%
Upper extremity 66 22%
Trunk 53 17%
Head and neck 3 1%
Depth Deep 166 54%
Superficial 139 46%
Diagnosis Myxofibrosarcoma 98 32%
Undifferentiated pleomorphic
sarcoma
207 68%
Grade (FNCLCC) Grade 2 55 18%
Grade 3 250 82%
Tumour size 5 cm 66 22%
>5 cm, 10 cm 152 50%
>10 cm 87 29%
UICC stage IIA 67 22%
IIB 115 38%
III 123 40%
Adjuvant
chemotherapy
Yes 13 4%
No 292 96%
Adjuvant
radiotherapy
Yes 245 80%
No 62 20%
Table 2
Local recurrence according to the surgical marginwidth and the use of radiotherapy.
Margin width Total No RT Adjuvant RT
LR %LR LR %LR LR %LR
Yes Total Yes Total Yes Total
0mm 11 59 19% 2 8 25% 9 51 18%
0.1e0.9mm 9 72 13% 2 9 22% 7 63 11%
1.0e1.9mm 4 70 6% 0 5 0% 4 65 6%
2.0e4.9mm 8 55 15% 2 13 15% 6 42 14%
5.0e9.9mm 2 12 17% 1 5 20% 1 7 14%
10.0mm 1 36 3% 0 22 0% 1 14 7%
Total 35 304 12% 7 62 11% 28 242 12%
Fig. 1. Cumulative probability of local recurrence stratified by margin classification; R-
classification (A), Rþ1-classification (B), three-group classification by metric distance
(C).
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no significant hazards for LR were observed for the R0 and R1 re-
sections (p¼ 0.650 by R classification; p ¼ 0.460 by Rþ1 classifi-
cation). On the other hand, macro-/microscopic positive margins
were significant hazards for LR with reference to 10 mm margin
(0 mm: HR, 12.730; 95% CI, 1.055e153.500; p ¼ 0.045
versus  10 mm: HR, 1). We identified a trend toward better local
control in patients receiving adjuvant radiotherapy in group 1 and 2
patients with a 10-year cumulative LR probability of 14% in patients
receiving adjuvant radiotherapy and 20% in patients who did not
receive adjuvant radiotherapy (p ¼ 0.078; Fig. 2).
Discussion
This study demonstrates the effect of resection margin in mil-
limetres on the risk of LR in infiltrative variants of STSs. Previous
investigations regarding the clinical significance of margin width
have been based on heterogeneous groups of STSs. King et al.
retrospectively reviewed 117 patients with STSs, comprising pleo-
morphic sarcoma (26.5%), myxoid liposarcoma (13.7%), leiomyo-
sarcoma (9.4%), synovial sarcoma (9.4%), MFS (7.7%), MPNST (6.0%),
and others [30]. The incidence of LR was similar in patients with
less than 1mm margin and greater than 1mm margins, and the
half of the LRs (2/4) occurred in MFS patients with <1mm and>5mm margin, respectively [30]. Sampo et al. reported that a
surgical margin of 2e3 cm provided reasonable local control in STSs
by the investigation of 270 STS patients [6]. In this report, MFH was
Table 3
Results of the Fine and Gray subdistribution hazards for local recurrence.
R-classification Rþ1-classification Three-group classification
Variable HR 95% CI p value Variable HR 95% CI p value Variable HR 95% CI p value
Size Size Size
5e10 cm vs 5 cm 2.067 0.793e5.385 0.140 5e10 cm vs 5 cm 2.098 0.797e5.525 0.130 5e10 cm vs 5 cm 1.979 0.754e5.199 0.170
>10 cm vs 5 cm 1.334 0.424e4.196 0.620 >10 cm vs 5 cm 1.358 0.423e4.355 0.610 >10 cm vs 5 cm 1.597 0.512e4.982 0.420
Depth Depth Depth
Deep vs superficial 1.143 0.562e2.324 0.710 Deep vs superficial 1.143 0.562e2.324 0.710 Deep vs superficial 1.259 0.591e2.680 0.550
Histological grade Histological grade Histological grade
Grade 2 vs grade 3 1.611 0.726e3.573 0.240 Grade 2 vs grade 3 1.638 0.739e3.631 0.220 Grade 2 vs grade 3 1.362 0.622e2.983 0.440
Radiotherapy Radiotherapy Radiotherapy
Used vs not used 0.644 0.277e1.501 0.310 Used vs not used 0.635 0.271e1.489 0.300 Used vs not used 0.419 0.159e1.103 0.078
Margin Margin Margin
R1 vs R0 1.280 0.437e3.746 0.650 R1 vs R0 1.381 0.582e3.278 0.460 0e10mm vs 10mm 5.624 0.488e64.750 0.170
R2 vs R0 5.923 2.393e14.660 <0.001 R2 vs R0 6.300 2.445e16.230 <0.001 0mm vs 10mm 12.730 1.055e153.500 0.045
Fig. 2. Cumulative probability of local recurrence in patients with less than 10mm
margins, stratified by the use of adjuvant radiotherapy.
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LR-free survival (69%) when compared to the other subtypes. This
suggests that a wider resection margin is required to reduce the
incidence of LR in tumour types known to have an infiltrative
growth pattern, and that what constitutes an adequate margin for
one histological variant may not apply to all histological variants.
We have demonstrated that neither the R-classification nor the
Rþ1-classification were able to stratify the risk of LR in patients
with negative margins, indicating that these classification systems
are not sufficiently sensitive to stratify what constitutes an
adequate margin of resection for infiltrative subtypes of STS.
However, when the margin was stratified according to the metric
distance from the tumour as 0 mm, 0.1e9.9 mm, and 10.0 mm, we
were able to demonstrate that the risk of LR was significantly
decreased when the margin of resection was 10 mm. Therefore,
we can recommend from these findings that for tumours with an
infiltrative growth pattern (eg MFS and UPS), a minimum resection
margin of at least 10 mm should be the aim to minimise the risk of
LR.
When exploring the effect of adjuvant radiotherapy on the risk
of LR, we observed a trend towards improvement in the cumulative
probablility of LR in patients with a margin of less than 10mm,
although this did not reach statistical significance. This could be
attributed to the fact that the majority of patients (80%) in the
present study received adjuvant RT; therefore, the number ofpatients in the untreated cohort was small. In a prospective rand-
omised study of 91 STS patients, Yang et al. demonstrated a sig-
nificant reduction in the probability of LR in those receiving
adjuvant radiotherapy [31]. However, this study comprised a cohort
of heterogeneous histological subtypes, which makes it difficult to
extrapolate the effect of margin and radiotherapy on the risk of LR.
Odei et al. reviewed 52 patients with MFS and reported that the use
of RT (preoperative, 19%; postoperative, 50%; and both, 2%) had no
significant effect on LR (p¼ 0.4675) or overall survival (p¼ 0.7377)
[32]. Similarly, Sanfillippo et al. investigated 158 MFS patients and
identified no correlation between the use of RT and LR (p¼ 0.753)
or overall survival (p¼ 0.342) [33]. Imanishi et al. investigated the
effect of preoperative RT in 8 superficial MFS and 10 superficial UPS.
The pathological response was a near-complete response (95%
non-viable area) in 60% of UPS but none of MFS. Of note, a total of 8
patients (62%; 7 MFS and 1 UPS) among 13 patients whose tail was
pathologically detected had viable or possibly viable tumour cells
in the tail [18]. Whether this represents an error in radiotherapy
planning in that the tails seen onMRI aremisinterpreted as oedema
rather than tumour infiltration, or this represents a relative resis-
tance of these tumour types to radiotherapy, is not clear. However,
what we can infer from our own findings, which support the
findings of others, is that the onlymodifiable variablewhich has the
most significant effect on the risk of LR is the margin that is ach-
ieved at resection.
We acknowledge several limitations to this study. First, we did
not attempt to correlate the histological findings with the preop-
erative radiological findings, particularly the margin dimension in
relation to the radiological tail. Further analyses regarding this
tumour-related factor would provide more detailed information on
themargin adequacy for these subtypes. Second, the data of margin
in millimetres were not available in all patients with negative
margin in the study period. Thus, the overall incidence of positive
marginal resections in this study appears higher than the actual
figure. Third, the details of radiotherapy, including dose and exact
field, could not be assessed, as radiotherapywas often administered
in regional centres whilst surgical resection was undertaken at a
single, supra-regional sarcoma centre. Forth, the margin quality
was not analysed in this study. Further analysis considering with
margin quantity, particularly in relation to the margin tissue in
deep MFS and UPS, would provide better a more accurate prog-
nostic indicator. If the quality of themargin could be predicted prior
to resection, particularly when the resection may require the close
dissection or even excision of nearby vital structures, it may be
possible to give more accurate information for preoperative
planning.
In conclusion, this study identified that in the case of MFS and
UPS, a margin in excess of 10mm was associated with the lowest
T. Fujiwara et al. / European Journal of Surgical Oncology 46 (2020) 277e281 281risk of LR. For these tumour types, a margin less than 10mm is
associatedwith a greater than 10% risk of LR, which does not showa
linear relationship. When assessing the effect of radiotherapy in
these specific tumour types, it appears that radiotherapy has a far
inferior effect on LR than the dimensions of the margin achieved at
surgical resection.
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